(Circulation. 1999;100:1727-1733.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
The Direct Antiatherogenic Effect of Estrogen Is Present, Absent, or Reversed, Depending on the State of the Arterial Endothelium
A Time Course Study in Cholesterol-Clamped Rabbits
From Novo Nordisk, Maaloev (P.H., E.E.); Center for Clinical and Basic Research, Ballerup (H.L.A.); and Clinical Institute, Odense University (M.R.A., S.S.), Denmark.
Correspondence to Pernille Holm, MD, Department of Women's Healthcare Biology, Novo Nordisk Park, 2760 Måløv, Denmark. E-mail PHlm{at}novo.dk
Background—This study further investigated the relationship between estrogen, arterial endothelium, and nitric oxide (NO) in cholesterol-clamped rabbits.
Methods and Results—Rabbits were ovariectomized, balloon-injured in the thoracic aorta, and grouped to receive cholesterol-enriched chow together with either 17ß-estradiol or vehicle for 1, 2, 4, or 8 weeks. In the undamaged aorta, cholesterol accumulation of the placebo rabbits was significantly increased from week 4 to 8 (P<0.001). This increase was almost completely inhibited by estrogen (P<0.001). In the balloon-injured aorta, the estrogen and placebo rabbits accumulated similar amounts of cholesterol in the reendothelialized areas. In the deendothelialized areas, the estrogen group surprisingly accumulated significantly more cholesterol than the placebo group. This difference was apparent from week 2 and became significant at week 8 (P<0.01). Circulating nitrite/nitrate were significantly increased by estrogen at weeks 1, 2, and 4 but not at week 8. Similarly, in additional experiments, basal NO release was significantly higher in estrogen-treated than in placebo-treated rabbits after 4 (P<0.05) but not after 8 weeks. Stimulated NO release and endothelial NO synthase activity did not differ between groups. Mononuclear-endothelial cell binding was reduced by 50% by estrogen after 4 weeks (P<0.05). This difference, however, was abolished by coadministration of NG-nitro-L-arginine methyl ester, an inhibitor of NO production.
Conclusions—The direct antiatherogenic effect of estrogen was present, absent, or reversed, depending on the state of the arterial endothelium, and preceded by a transient increase in NO production followed by a reduced mononuclear-endothelial cell binding.
Key Words: atherosclerosis • balloon • endothelium • estrogen • nitric oxide
This article has been cited by other articles:
 |
|
 |
|
  S. Kreijkamp-Kaspers, L. Kok, M. L Bots, D. E Grobbee, J. W Lampe, and Y. T van der Schouw Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women Am. J. Clinical Nutrition, January 1, 2005; 81(1): 189 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stampfer Commentary: Hormones and heart disease: do trials and observational studies address different questions? Int. J. Epidemiol., June 1, 2004; 33(3): 454 - 455. [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. Col and S. G. Pauker The Discrepancy between Observational Studies and Randomized Trials of Menopausal Hormone Therapy Ann Intern Med, May 4, 2004; 140(9): 765 - 766. [Full Text] [PDF]
|
|
|
|
|
|
F. Grodstein, J. E. Manson, M. J. Stampfer, and W. C. Willett The Discrepancy between Observational Studies and Randomized Trials of Menopausal Hormone Therapy Ann Intern Med, May 4, 2004; 140(9): 764 - 765. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lokkegaard, Z. Jovanovic, B. L. Heitmann, N. Keiding, B. Ottesen, Y. A. Hundrup, E. B. Obel, and A. T. Pedersen Increased Risk of Stroke in Hypertensive Women Using Hormone Therapy: Analyses Based on the Danish Nurse Study Arch Neurol, October 1, 2003; 60(10): 1379 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Noel Bairey Merz, B. D. Johnson, B. L. Sharaf, V. Bittner, S. L. Berga, G. D. Braunstein, T. K. Hodgson, K. A. Matthews, C. J. Pepine, S. E. Reis, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study J. Am. Coll. Cardiol., February 5, 2003; 41(3): 413 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Chambliss and P. W. Shaul Estrogen Modulation of Endothelial Nitric Oxide Synthase Endocr. Rev., October 1, 2002; 23(5): 665 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Byington, C. D. Furberg, D. M. Herrington, J. A. Herd, D. Hunninghake, M. Lowery, W. Riley, T. Craven, L. Chaput, C. C. Ireland, et al. Effect of Estrogen Plus Progestin on Progression of Carotid Atherosclerosis in Postmenopausal Women With Heart Disease: HERS B-Mode Substudy Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1692 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Koh, J. Y. Ahn, D. K. Jin, B.-K. Yoon, H. S. Kim, D. S. Kim, M.-S. Shin, J. W. Son, I. S. Choi, and E. K. Shin Effects of Continuous Combined Hormone Replacement Therapy on Inflammation in Hypertensive and/or Overweight Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1459 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Koh Effects of estrogen on the vascular wall: vasomotor function and inflammation Cardiovasc Res, September 1, 2002; 55(4): 714 - 726. [Full Text] [PDF]
|
|
|
|
|
|
H. Y. Chan, X. Yao, S. Y. Tsang, J.-P. Bourreau, F. L. Chan, and Y. Huang Isoproterenol amplifies 17{beta}-estradiol-mediated vasorelaxation: role of endothelium/nitric oxide and cyclic AMP Cardiovasc Res, February 15, 2002; 53(3): 627 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Chang and T. A. Stein Ten-Year Outcome After Saphenous Vein Patch Angioplasty in Males and Females After Carotid Endarterectomy Vascular and Endovascular Surgery, January 1, 2002; 36(1): 21 - 27. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Amant, P. Holm, S.-h. Xu, N. Tritman, M. Kearney, and D. W. Losordo Estrogen Receptor-Mediated, Nitric Oxide-Dependent Modulation of the Immunologic Barrier Function of the Endothelium: Regulation of Fas Ligand Expression by Estradiol Circulation, November 20, 2001; 104(21): 2576 - 2581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Losordo and J. M. Isner Vascular endothelial growth factor-induced angiogenesis: crouching tiger or hidden dragon? J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2131 - 2135. [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Dubey and E. K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Herrington, D. M. Reboussin, K. B. Brosnihan, P. C. Sharp, S. A. Shumaker, T. E. Snyder, C. D. Furberg, G. J. Kowalchuk, T. D. Stuckey, W. J. Rogers, et al. Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis N. Engl. J. Med., August 24, 2000; 343(8): 522 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R Andersen and S. Stender Endothelial nitric oxide synthase activity in aorta of normocholesterolemic rabbits: regional variation and the effect of estrogen Cardiovasc Res, July 1, 2000; 47(1): 192 - 199. [Abstract] [Full Text] [PDF]
|
|